₹860.0
-0.41% today
· 30d +24.1%
as of 2026-09-04
Price · Daily Candles
AI narrative is temporarily unavailable for AARTIPHARM. The deterministic sections below render from live data.
₹ Latest Earnings · Q ending 2026-03-31
REVENUE
₹583 Cr
+3.35% YoY
NET PROFIT
₹61 Cr
-30.81% YoY
OPM
20.52%
-5.1pp YoY
EPS
₹6.74
PE 38.19
Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-1.9% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.
ML Forward Growth Predictions 🔒
57
SCORE / 100
Overall
6-axis composite of the sections below.
Performance
POSITIVE
55
Valuation
FAIR
40
Growth
DECLINING
25
Profitability
HIGH
78
Technicals
NEUTRAL
63
Risk
LOW
80
Key Stats
TTM PE
38.19
P/B
3.68
52W HIGH
₹946.1
OFF HIGH
-9.1%
DIV YIELD
0.47%
MKT CAP
₹7796 Cr
◉ Active Signals
MACDNeutral-2.3842
RSI(14)Bullish62.17
Street Consensus
1 analyst₹740.0
mean target
Low ₹740.0Now ₹860.0High ₹740.0
⧉ Strategy Fit 🔒